IFP Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.8K Buy
507
+110
+28% +$10.1K ﹤0.01% 2539
2026
Q2
$40.9K Sell
397
-681
-63% -$40K ﹤0.01% 2530
2026
Q1
$41.2K Buy
+1,078
New +$34.1K ﹤0.01% 2357
2025
Q2
– Hold
0
– – – 3768
2025
Q1
– Hold
0
– – – 3472
2024
Q4
– Hold
0
– – – 3479
2022
Q4
– Sell
-8
Closed -$1K – 4602
2022
Q3
$1K Hold
8
– – ﹤0.01% 4497
2022
Q2
$1K Hold
8
– – ﹤0.01% 4275
2022
Q1
$1K Buy
+8
New +$438 ﹤0.01% 4275

Other funds holding ATEX

IFP Advisors's ATEX Position: Q3 2026 in Review

IFP Advisors increased its Anterix (ATEX) stake by 28% in Q3 2026, buying an estimated $10.1K and bringing the position to 507 shares worth $39.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

IFP Advisors first reported a position in ATEX in Q1 2022 and has held it in 6 quarters since. The position peaked at $41.2K in Q1 2026. 57 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.

  • IFP Advisors held 507 shares of Anterix worth $39.8K as of Q3 2026.
  • IFP Advisors bought 110 Anterix shares in Q3 2026, an estimated $10.1K.
  • Anterix made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2539 holding.
  • IFP Advisors first reported a position in Anterix in Q1 2022 and has held it in 6 quarters since.
  • IFP Advisors's Anterix position peaked at $41.2K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held Anterix as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.